Biolin Scientific, a Sweden based peer backed by private equity firm Ratos, has acquired the Sophion stake from NeuroSeach for an undisclosed amount.
Nasdaq-listed drugs company NeuroSearch has agreed to sell its 30.1% stake in medical technology maker Sophion Bioscience.
Biolin Scientific, a Sweden based peer backed by private equity firm Ratos, has acquired the Sophion stake from NeuroSeach for an undisclosed amount.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
